Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benoxinate Hydrochloride for Pain in ROP Screening
NCT06461975Phase 3Completed
- Sponsor
- Alexandria University
- Start
- Jan 2023
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxybuprocaine in retinopathy of prematurity (ROP), sponsored by Alexandria University. Started Jan 2023; status: completed.
02
Drugs
oxybuprocaine
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT06461975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06461975.